Photys Therapeutics Announces Research Collaboration with Novo Nordisk to Develop Induced Proximity PHICS Technology for Cardiometabolic Diseases
2024-12-18manilatimes

"We are excited to bring together Novo Nordisk's leadership and expertise in cardiometabolic diseases with our unique induced proximity PHICS technology with the goal of advancing a new class of medicines for patients," said Brian Fenton, President a ...undefined